Skip to content
The Policy VaultThe Policy Vault

SunosiMedical Mutual

Excessive Daytime Sleepiness associated with Obstructive Sleep Apnea (OSA)

Initial criteria

  • Patient age ≥ 18 years
  • Diagnosis of obstructive sleep apnea has been confirmed, according to the prescriber
  • Sunosi is prescribed by or in consultation with a sleep disorder specialist, psychiatrist, or neurologist
  • Sunosi will be used in conjunction with continuous positive airway pressure (CPAP) OR Patient is unable to initiate or tolerate CPAP therapy
  • Patient has tried generic modafinil or generic armodafinil

Reauthorization criteria

  • Response to therapy is required for continuation of therapy

Approval duration

1 year